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https://doi.org/10.1016/j.celrep.2020.108488SUMMARYThe coronavirus disease 2019 (COVID-19) pandemic causedby severe acute respiratory syndromecoronavirus
2 (SARS-CoV-2) has precipitated an unprecedented and yet-unresolved health crisis worldwide. Different
mammals are susceptible to SARS-CoV-2; however, few species examined so far develop robust clinical dis-
ease that mirrors severe human cases or allows testing of vaccines and drugs under conditions of severe dis-
ease. Here, we compare the susceptibilities of three dwarf hamster species (Phodopus spp.) to SARS-CoV-2
and introduce the Roborovski dwarf hamster (P. roborovskii) as a highly susceptible COVID-19 model with
consistent and fulminant clinical signs. Particularly, only this species shows SARS-CoV-2-induced severe
acute diffuse alveolar damage and hyaline microthrombi in the lungs, changes described in patients who suc-
cumbed to the infection but not reproduced in any experimentally infected animal. Based on our findings, we
propose the Roborovski dwarf hamster as a valuable model to examine the efficacy and safety of vaccine can-
didates and therapeutics, particularly for use in highly susceptible individuals.INTRODUCTION
The coronavirus disease 2019 (COVID-19) epidemic is caused by
the human severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) (Andersen et al., 2020; Bedford et al., 2020; Paules
et al., 2020). The COVID-19 situation is still evolving rapidly, with
alarming levels of spread in somegeographic regions and disease
severity, especially in the elderly and patients with pre-existing
conditions (Davies et al., 2020; Dong et al., 2020). In the search
for countermeasures against the pandemic, there is an unprece-
dented quest for the development of suitable animal models to
study all presentations of COVID-19 (Lakdawala and Menachery,
2020; Yuanet al., 2020).Development of suchamodel is of utmost
importance to unravel virus-inducedpathogenesis and toevaluate
vaccinecandidatesandpotential therapeutic strategies.However,
all of the currently available animal models are imperfect, and
especially transgenic animals are in short supply (Callaway,
2020). Specifically, SARS-CoV-2 infection of all animal models re-
ported so far resulted in rather mild illness, commonly character-
ized by no or moderate weight loss and signs of respiratory tract
infection. Systemic disease has, although frequently reported in
humans (Gupta et al., 2020; Tayet al., 2020), so far not consistentlyC
This is an open access article under the CC BY-Nbeen observed in experimental infections of animals. Notably,
virtually all experimental infections of animal models eventually
lead to full recovery, which evidently is not the case in humans
(Lakdawala and Menachery, 2020; Yuan et al., 2020). Currently
used species were primarily selected to fit in silico predictions of
susceptibility based on similarity to the human receptor of
SARS-CoV-2, angiotensin converting enzyme-2 (ACE-2) (Devaux
et al., 2020; Li et al., 2020; Pach et al., 2020). The animal models
tested range from non-human primates (Deng et al., 2020; Lu
et al., 2020b; Yu et al., 2020) to ferrets (Kim et al., 2020; Richard
et al., 2020), mice (Bao et al., 2020; Dinnon et al., 2020; Gu et al.,
2020; Hassan et al., 2020; Sun et al., 2020), cats (Shi et al.,
2020), and hamsters (Bertzbach et al., 2020). In particular, recent
SARS-CoV-2 hamster studies made use of the Syrian hamster
(Mesocricetus auratus), which develops only moderate signs of
clinical disease and lung pathology (Chan et al., 2020; Imai et al.,
2020; Kreye et al., 2020; Sia et al., 2020), although age-related dif-
ferences were reported (Osterrieder et al., 2020).
Dwarf hamster species have been used as animal models in
biomedical research, mainly in endocrinology, theriogenology,
and circadian biology research (Munley et al., 2018; Scherbarth
and Steinlechner, 2010). To date, however, dwarf hamsters wereell Reports 33, 108488, December 8, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Changes in Body Temperature and Body Weight Following SARS-CoV-2 Infection in Phodopus Hamsters
(A–C) Temperature changes of (A) Roborovski dwarf hamsters, (B) Campbell’s dwarf hamsters, and (C) Djungarian hamsters over the course of infection (shown
as means with SD of at least 12 [2 and 3 dpi], 7 [5 dpi], and 6 animals [after 5 dpi] per group).
(D–F) Corresponding individual relative body weights of (D) Roborovski dwarf hamsters (n = 22), (E) Campbell’s dwarf hamsters (n = 24), and (F) Djungarian
hamsters (n = 24) are given. The color code represents mock-infected animals (green) or Phodopus hamsters infected with the low dose (blue) or standard dose
(red) (Wichmann et al., 2020).
The dotted lines at 85% in (D)–(F) refer to 15%body weight losses (first defined humane endpoint). Mann-Whitney U tests (B, C, E, and F) and Kruskal-Wallis tests
(A and D) for each time point revealed significant differences in body temperatures and body weights of infected versus non-infected Roborovski dwarf hamsters
at 2 and 3 dpi (***p % 0.0001, **p % 0.001).
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outcome of SARS-CoV-2 infection in three closely related yet
genetically distinct dwarf hamster species of the genus Phodopus.
We observed striking differences in disease susceptibility among
these species, a phenomenon apparently independent of their
ACE-2 sequence. All residues shown to mediate interaction with
the SARS-CoV-2 spike glycoprotein, which is deemed the decisive
factor for susceptibility to the infection (Ou et al., 2020), are
conserved among the hamsters compared in this study. Here, we
demonstrate that all threePhodopusspecies testedaresusceptible
to the infection. However, only the Roborovski dwarf hamsters
(P. roborovskii) developed a rapid onset of fulminant clinical dis-
ease. Therefore, this infectionmodelmimics the clinical and patho-
logical outcome observed in severe cases of COVID-19 better than
anyother availablemodel. It can thus serveas a valuablealternative
and a highly sensitivemodel in the development and testing of anti-
viral treatments, as well as other pro- andmetaphylactic therapies.
RESULTS
Clinical Disease
Roborovski dwarf hamsters (P. roborovskii), Campbell’s
dwarf hamsters (P. campbelli), and Djungarian hamsters2 Cell Reports 33, 108488, December 8, 2020(P. sungorus) were infected with 1 3 105 plaque-forming
units (pfu) of SARS-CoV-2 and inspected daily for up to
14 days. We observed changes in body temperatures,
body weights, and clinical signs at early time points post-
infection (Figure 1). While these parameters did not signifi-
cantly differ between mock-infected and infected Campbell’s
or Djungarian dwarf hamsters (Figures 1B, 1C, 1E, and 1F),
infected Roborovski dwarf hamsters exhibited consistent
and fulminant clinical signs within 3 days following infection.
We recorded a dramatic decrease of body temperatures
following infection, with a reduction in mean body tempera-
tures from 36C at 1 day post-infection (dpi) to 33.1C ±
1.1C standard deviation (SD) at 2 dpi and 30.2C ± 0.4C
SD at 3 dpi (Figure 1A). Moreover, mean weight losses
reached 14.35% ± 2.96% SD (2 dpi) and 19.86% ± 2.68%
SD on 3 dpi when compared to the mock-infected group
(Figure 1D). Roborovski dwarf hamsters also showed clear
signs of clinical disease including snuffling, dyspnea, and
ruffled fur. Overall, the very active behavior otherwise typical
for this species was dramatically reduced. Three days after
infection, multiple individuals appeared to be terminally ill.
For humane reasons, all infected Roborovski dwarf hamsters
were euthanized at this point.
Figure 2. Virus Loads in the Respiratory
Tract and Whole-Blood Samples
(A and B) Virus titers in 50-mg lung tissues were
determined by plaque assay in Vero E6 cells (A)
and virus genome copy numbers per 2.5-mg lung
tissue as determined by qRT-PCR at different time
points after infection (B).
(C and D) Virus loads were also determined by
qRT-PCR in (C) bucco-laryngeal swabs and (D)
2.5 ml of whole-blood samples. Kruskal-Wallis
tests were employed to determine significant dif-
ferences between the Phodopus hamsters. Shown
are results for Roborovski dwarf hamsters infected
with the standard dose (black circles, n = 2 at 2 dpi,
n = 8 at 3 dpi) and low dose infection (white circles,
n = 2 at 4 dpi, n = 1 at 5 dpi), Campbell’s dwarf
hamsters (dark gray circles, n = 3 at all time points),
and Djungarian hamsters (light gray circles, n = 3 at
all time points). Significant differences are marked
with asterisks (*) and indicate a p value of % 0.05.
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re-used three uninfected animals intended as controls for the
now-obsolete later time points after infection. The three remain-
ing animals were infected with 5,000 pfu of SARS-CoV-2, a dose
reduction of 95% compared to the initial challenge. Weight loss
observed in these hamsters was only slightly delayed compared
to the standard dose challenge; however, the decrease of body
temperatures was less pronounced, and dyspnea was the only
prominent clinical sign in the low dose challenge group (Figures
1A and 1D). Regardless of the overall milder disease progres-
sion, all three animals included in the low dose challenge
reached the defined humane endpoints by 4 or 5 dpi. The body
weight losses observed in Djungarian hamsters (Figure 1C)
were less pronounced and rather transient, mirroring the course
of infection described for Syrian hamsters (Chan et al., 2020; Imai
et al., 2020; Osterrieder et al., 2020; Sia et al., 2020). While de-
creases of mean body temperatures were observed in this spe-
cies after infection, they proved to be highly inconsistent be-
tween individuals. From the three species compared here,
Campbell’s dwarf hamsters were the least susceptible to clinical
disease following SARS-CoV-2 infection, as evidenced by amild
or completely absent reduction of body weight and no decline of
body temperature. In addition, and in particularly stark contrast
to infected Roborovski dwarf hamsters, no clinical signs were
observed in this species following SARS-CoV-2 infection.Virological Assessment
In the next series of experiments, we determined virus titers and
SARS-CoV-2 RNA copy numbers in the lungs, bucco-laryngeal
swabs, and whole-blood samples of all hamsters (Figure 2). Re-Cesults confirmed readily detectable and
high virus loads in respiratory samples at
early time points after infection in all spe-
cies tested (Figures 2A–2C). We found
significantly higher virus titers in the lungs
of Roborovski dwarf hamsters at 3 dpi
when compared to the other two species(Figure 2A). Notably, we detected viral RNA copies of 2.06 3
106 ± 2.37 3 106 SD (2 dpi) and 1.81 3 106 ± 1.69 3 106 SD (3
dpi) in bucco-laryngeal swabs of Roborovski dwarf hamsters,
while copy numbers reached a maximum of only 1 3 105 in
Campbell’s and Djungarian hamsters at these time points (Fig-
ure 2C). Virus copy numbers detected in blood samples indicated
a potential viremic spread in select individuals of all three species
(Figure 1D). By virus titrations of the blood collected from infected
dwarf hamsters, we detected infectious virus at titers ofmore than
100 pfu/mL blood in some but not all infected animals (Table S1).
We followed up on the question of systemic virus spread by
determining virus loads in jejunal and kidney samples of all in-
fected Roborovski dwarf hamsters at different time points after
infection (Figure 3A and 3B). As determined by qRT-PCR, we de-
tected relatively high viral RNA copy numbers in both organs at
all time points, confirming systemic, extrapulmonary spread of
the virus in all individuals of this species.
Finally, using qRT-PCR, we found fewer than 1,000 copies of
virus RNA per 2.5 mg of brain tissue, which suggests a lack of
productive infection of the brain (Table S1).
Histopathology
Similar to themarkedclinical differencesobservedamong the three
hamster species followingSARS-CoV-2 infection, a systematic his-
topathological examination of formalin-fixed, paraffin-embedded
lung sections following recommended guidelines (Gruber et al.,
2020) revealed striking differences, both in terms of lesion charac-
tersaswell as their distribution andseverities (TableS2).Most obvi-
ously, only theRoborovski dwarf hamsters infectedwith13105pfu
(standard dose) developed highly destructive and diffuse alveolarll Reports 33, 108488, December 8, 2020 3
Figure 3. Virus Loads in Intestinal and Kidney Samples of Infected
Roborovski Dwarf Hamsters
Virus loads in 2.5 mg of (A) jejunal and (B) kidney tissues of animals infected
with the standard dose (black circles) or low dose (white circles). Viral RNA
copies were determined by qRT-PCR at different time points after infection
and revealed systemic virus spread.
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cell (AEC) necrosis, hyaline membranes, proteinaceous material,
hemorrhages, edema, and cellular debris within alveoli as early as
2 dpi (Figures 4A and 4C). Of note, marked hyaline thrombi were
present in high numbers of interalveolar wall capillaries with strong
purple signals in a periodic acid Schiff (PAS) reaction (Figure 4C,
inset). However, contrary to previous reports on Syrian hamsters
(Gruber et al., 2020; Imai et al., 2020; Osterrieder et al., 2020), the
bronchitis component wasmild (Figure 4B) or absent, and vascular
endothelialitis was not observed. Attempts of regeneration in terms
of hyperplasia of AEC or bronchial epithelium (BE) were not
observed until 3 dpi, probably due to the overwhelming and early
parenchymal destruction. Importantly, these patterns were uni-
formly present in all hamsters of this group.
In contrast, all Roborovski dwarf hamsters infected with 1/20 of
the standard dose (5,000 pfu, low dose) still developed patholog-
ical patterns typical of experimental SARS-CoV-2 infection, as
previously described in Syrian hamsters (Chan et al., 2020; Gruber
et al., 2020; Imai et al., 2020; Kreye et al., 2020; Osterrieder et al.,
2020; Sia et al., 2020). These included necrosuppurative pneu-
monia distributed multifocally throughout the lungs as well as
ongoing bronchitis with hyperplasia of BE and AEC at 4 and 5
dpi (Figures 4E–4G). Hyaline thrombi were not observed (Fig-
ure 4G), but vascular endothelialitis was sporadically present.
Infection of the Djungarian and Campbell’s dwarf hamsters re-
sulted in overall similar tissue damage and inflammatory reac-
tions at 2 to 5 dpi that resembled the Roborovski dwarf hamsters
infected with the low dose (Figure S1). In strong contrast to the
latter infected with the same (standard) dose, both species
showed early and prominent onset of AEC hyperplasia from 3
dpi on, indicating active regeneration. Hyaline thrombi or
vascular endothelialitis were not observed in any animal of
both species (Table S2). In addition to lungs, systematic histo-
pathological examinations of all hamster brains failed to yield
any evidence of cellular or tissue damage, inflammatory re-
sponses, circulatory disturbances such as thrombosis and hem-
orrhage, or any other evidence of viral infection. Moreover, PAS4 Cell Reports 33, 108488, December 8, 2020reaction on histological sections of all brains did not reveal any
evidence of hyaline thrombosis, as seen in disseminated intra-
vascular coagulation.
In Situ Hybridization of SARS-CoV-2 RNA
In the Roborovski dwarf hamsters infected with the standard
dose, viral RNA encoding for the N protein of SARS-CoV-2
was localized throughout the entire lungs, consistent with the ho-
mogeneous distribution of lesions. Specifically, the virus was
found mainly in AEC-II but also in bronchi and macrophages,
while AEC-I were uniformly negative (Figure 4D; Table S2).
Following low dose infection, a distribution of virus nucleic acid
similar to the standard dose group was observed (Figure 4H).
However, under low dose conditions, regions with dense im-
mune cell infiltration were consistently devoid of viral RNA.
In the Djungarian and Campbell’s dwarf hamsters, viral RNA
was strictly localized to the vicinities of inflammatory foci. In
contrast to the Roborovski dwarf hamsters, however, both
AEC-I and AEC-II were equally infected (Figures S1D and
S1H). Bronchial epithelial cells, detritus lining the bronchial mu-
cosa, and macrophages also contained viral RNA, as observed
in the Roborovski dwarf hamsters (Table S2).
Detailed examination of the brains of infected Roborovski dwarf
hamsters by in situ hybridization for SARS-CoV-2 RNA failed to
identify any viral RNA signals in the entire brains, including the
rhinencephalon. Only rare signals were detected in single blood
leukocytes within blood vessels, consistent with viremia.
Comparison of ACE-2 Sequences between Different
Hamster Species
One of the major determinants of susceptibility to SARS-CoV-2 is
the ability of its spike glycoprotein (S) to bind to its cognate recep-
tor, ACE-2,which is deemednecessary for virus entry into the host
cell (Hoffmann et al., 2020). To investigate the potential role of
ACE-2 sequence variation in the diverging course of SARS-
CoV-2 infection in Phodopus species, we determined the full-
length coding sequence of the Roborovski dwarf hamster ACE-
2 by PCR amplification and Sanger sequencing and assembled
the coding sequence of ACE-2 of the Djungarian hamster from
publicly available shotgun sequencing data (GenBank:
GCA_001707965.1). Comparison of the newly obtained and the
published ACE-2 sequence of the Campbell’s dwarf hamster
and the Syrian hamster revealed several single-nucleotide poly-
morphisms (SNPs) (Figure 5). However, we failed to identify any
difference in any of the amino acids thought to be critically impor-
tant for virus binding (Figure 5) (Lan et al., 2020; Shang et al., 2020;
Wan et al., 2020). We concluded from our data that the minor dif-
ference in the primary structure of ACE-2 is likely insufficient to
explain the remarkable susceptibility of the Roborovski dwarf
hamster to SARS-CoV-2 infection and the development of severe
disease when compared to other hamster species examined here
or in previous studies (Chan et al., 2020; Imai et al., 2020; Oster-
rieder et al., 2020; Sia et al., 2020).
DISCUSSION
In this study, we compare the susceptibility of three Phodopus
dwarf hamster species to SARS-CoV-2 infection and introduce
Figure 4. Lung Histopathology and In Situ Hybridization of SARS-CoV-2-Infected Roborovski Dwarf Hamsters
(A–D) Following infection with 13 105 plaque-forming units (pfu, standard dose; A–D) P. roborovskii developed devastating diffuse lung damage at 3 dpi (A) with
only mild necrosis of bronchial epithelium (BE) and bronchitis (B) but severe diffuse alveolar damage, including necrosis of alveolar epithelial cells (AECs; C,
arrows), hyalinemembranes and fibrin extravasation (C, arrowhead), hemorrhage and alveolar edema, aswell asmultiple hyaline thrombi in alveolar capillaries (C,
inset, arrowheads; PAS reaction). Consistent with the homogeneous distribution of lesions, in situ hybridization localized viral RNA throughout the entire lungs
predominantly within AEC-II (D, inset, arrowheads) but also in bronchi (D, hash) and macrophages, while AEC-I were completely spared.
(E–H) Infection with 20-times-less virus (53 103 pfu, low dose; E–H) still resulted in extensive pneumonia at 4 dpi (E) with inflammation and regeneration of BE (F,
arrows), necrosis of AEC and inflammatory cells (G, arrow), as well as mainly neutrophilic and heterophilic infiltration (G, arrowhead). Viral RNA was detected with
a distribution similar to the standard dose group; however, areas of dense inflammation had obviously cleared the virus (H, hash). Red, signals for viral RNA; blue,
hemalaun counterstain.
(I–L) Mock-infected animals developed none of the pathologic findings of animals infected with SARS-CoV-2.
Bars: 1 mm (A, E, and I), 50 mm (B, C, F, G, J, and K), 200 mm (D, H, and L), and 20 mm (insets of C, H, and K).
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ceptible species that develops—as the only naturally susceptible
COVID-19 animal model described to date—significant body
weight loss, severe reduction in body temperature, consistent
systemic viral spread, and dramatic clinical signs within 48 h of
infection. Dose dependency is observed in the course of dis-
ease; however, even animals challenged with a 20-fold-reduced
dose develop only slightly protracted, yet still fulminant and
consistent, disease progression. Notably, our findings stand in
contrast to data that suggest rather low SARS-CoV-1 suscepti-
bility of dwarf hamsters (Li et al., 2012).
Compared to the Syrian hamster and other available naturally
susceptible animal models, the Roborovski dwarf hamster offers
the advantage of rapid and consistent development of clinical
signs following infection. This is important not only to increasethe validity and significance of preclinical trials, but it may also
allow a reduction of animal numbers, as statistically significant
differences may be achieved more easily. Alongside the partic-
ular features described in this study, the Roborovski dwarf ham-
ster offers the practical advantage of a much smaller size
compared to Syrian hamsters: it does not, in fact, reach the
size of a mouse and is thus the smallest model available.
Compared to other hamster species, it also was less prone to
aggressive behavior, which facilitated both handling and housing
in larger groups. Notably, Roborovski dwarf hamsters are
commercially available and bred in large numbers for pet trade.
The species reaches sexual maturity at 4 weeks of age and can
easily be bred in a laboratory environment (Kubiak, 2020).
The rapid and fatal course of experimental infection of Robor-
ovski dwarf hamsters mirrors the situation in severe COVID-19Cell Reports 33, 108488, December 8, 2020 5
Figure 5. Comparison of Genomic ACE-2 Sequences
ACE-2 residues that interact with the receptor-binding domain (RBD) of SARS-CoV-2 spike glycoprotein (S) are almost completely conserved among different
species of the family Cricetidae (the only exception is ACE-2 residue 354G/E). The interacting residues of the two proteins are highlighted in grey shading. Amino
acids are colored according to their physico-chemical properties: red, hydrophobic; blue, negatively charged; pink, positively charged; purple, small nonpolar;
green, polar residue. Asterisk, fully conserved residue; colon, residue with very similar properties.
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alveolar damage and hyaline microthrombi were readily detect-
able in infected animals within days after standard dose chal-
lenge (McGonagle et al., 2020). Of note, no other animal model
described so far developed these lesions at a comparable
severity observed in the Roborovski dwarf hamster (Bertzbach
et al., 2020; Chan et al., 2020; Cleary et al., 2020; Gruber et al.,
2020; Imai et al., 2020; Kreye et al., 2020; Rockx et al., 2020;
Yu et al., 2020). It is worthmentioning that we could exclude rele-
vant involvement of the brain in SARS-CoV-2 infection of Robor-
ovski dwarf hamsters. Importantly, transgenic mice that show
robust disease development frequently suffer from severe
SARS-CoV-2-induced encephalitis (Jiang et al., 2020; Winkler
et al., 2020), a cause of death not observed in humans. Thus,
the severe pneumonia with thrombosis observed in the Roborov-
ski dwarf hamster is a much closer resemblance of severe and
fatal human cases of COVID-19.
Our findings allow us to conclude that comparison of disease
progression is possible within a wide range of virus infection
doses. This aspect is particularly important for future testing of
the robustness of therapeutics and vaccines with respect to se-
vere outcomes as well as the safety of live attenuated vaccines.
Considering the unabated spread of the virus in large parts of the
world, such vaccines are desperately needed to effectively com-
bat the pandemic. A major and valid concern regarding the
safety of live attenuated vaccines is the potential for residual
virulence or reversion to virulence of the vaccine virus that may
then cause disease in vaccines. Reducing the potential hazard
of releasing an even mildly virulent vaccine virus can be mini-
mized only by testing vaccine candidates in a highly susceptible
model prior to clinical trials. The Roborovski dwarf hamster
seems, so far, to be the only naturally susceptible animal that
would provide the sensitivity required for such absolutely neces-
sary studies.
Moreover, infection of the highly susceptible Roborovski dwarf
hamster as demonstrated here suggests that COVID-19 disease
outcome in terms of clinical symptomsmight be somewhat inde-
pendent of the infectious dose, provided that the minimal infec-
tious dose is reached. However, the dynamics of disease pro-6 Cell Reports 33, 108488, December 8, 2020gression in an individual may well be a function of infectious
dose, and informed decisions regarding therapeutic intervention
or pro- and metaphylactic measures are absolutely critical for an
appropriate medical response at the different stages of infection
with SARS-CoV-2. A complete understanding of disease devel-
opment over time following infection with different doses,
including the important question of systemic spread of the virus,
in the absence or presence of any type of intervention will be
absolutely necessary for an adequate individual and population
response (Tay et al., 2020). This aspect may become even
more important in the future, as new strains have been evolving
that seem to spread extremely effectively in the human popula-
tion but may also undergo attenuation (Forster et al., 2020;
Korber et al., 2020; Lu et al., 2020a). In such a scenario, the avail-
ability of a highly susceptible animal model will be key to ad-
dressing pertinent questions of mitigation strategies and spread
of infection.
The ability of ACE-2 to bind the SARS-CoV-2 receptor-binding
domain (RBD) located in the spike protein is so far deemed to be
the major determinant of species susceptibility to SARS-CoV-2
infection (Ou et al., 2020; Shang et al., 2020; Wan et al., 2020;
Zhai et al., 2020). While our data do not provide any reason to
question this paradigm, we discovered only minor differences
in the ACE-2 protein of Phodopus species. Since none of the
amino acids described to be of importance for virus RBD binding
are altered among the three species, we consider it unlikely that
the substantial differences in disease progression can be ac-
counted for by differences in ACE-2 RBD binding.
Differences in other factors important for virus infection, such
as the transmembrane serine protease 2 (TMPRSS2), are less
understood. The same holds true for other intrinsic host factors,
such as differences in innate and adaptive immune responses,
different expression levels and tissue distributions of ACE-2,
and the tendency to develop coagulopathy following SARS-
CoV-2 infection. We believe the Roborovski dwarf hamster can
serve as a model to better understand these principles underly-
ing the highly variable pathologies of COVID-19. It seems impor-
tant to emphasize that we find that all tested species are suscep-
tible to the infection, and virological parameters—albeit slightly
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explain the striking differences in the observed disease pheno-
types. The Roborovski dwarf hamster may, thus, also offer in-
sights into the mechanisms and modulating factors underlying
the severe course of infection. Still, this model comes with the
caveat of a lack of generally available tools and reagents that
would allow to readily measure host factors including immune re-
sponses (e.g., chemokines or cytokines), at least on the protein
level.
In summary, we document that the P. roborovskii small-animal
model for SARS-CoV-2 infection is an asset to animal models
described to date because infection, even with low virus doses,
results in rapid and robust development of severe clinical dis-
ease due to early destructive and fatal lung pathology, while rele-
vant central nervous system infection is not observed. Impor-
tantly, variation of virus doses of infection allows for following
disease progression and spans awide spectrum of clinical signs,
from a respiratory-only to a severe and systemic outcome.
Therefore, we contend that the Roborovski dwarf hamster may
serve as a valuable addition to the animal models available to
examine SARS-CoV-2 pathogenesis; the safety and efficacy of
vaccines, particularly for modeling highly susceptible individ-
uals; as well as the safety and efficacy of therapeutic or meta-
phylactic interventions.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Ethics statement
In vitro and animal work was conducted under appropriate biosafety conditions in the BSL-3 facility at the Institut f€ur Virologie, Freie
Universität Berlin, Germany. All animal experimentation was approved by the Landesamt f€ur Gesundheit und Soziales in Berlin,e1 Cell Reports 33, 108488, December 8, 2020
Report
ll
OPEN ACCESSGermany (permit number 0086/20) and performed in compliance with relevant national and international guidelines for care and hu-
mane use of animals.
Viruses and cells
We used the previously published SARS-CoV-2 M€unchen isolate (Wölfel et al., 2020) for virus challenge. Virus stocks were propa-
gated on Vero E6 cells (ATCC CRL-1586) in minimal essential medium (MEM; PAN Biotech) that was supplemented with 10% fetal
bovine serum (PAN Biotech), 100 IU/ml penicillin G and 100 mg/ml streptomycin (Carl Roth). The virus stocks were stored at 80C
prior to experimental infections.
Hamsters
This study involved the three members of the genus Phodopus of the hamster subfamily Cricetinae: Roborovski dwarf hamsters
(P. roborovskii), Campbell’s dwarf hamsters (P. campbelli) and Djungarian hamsters (P. sungorus) obtained through the German
pet trade. All animals were sourced from the same breeding facility. For each species, 22 to 24 female and male hamsters of 5 to
7 weeks of age were kept in groups of 6 animals in individually ventilated cages. Enrichment was provided bountiful according to
provisions of the animal experimentation guidelines and legal requirements. Hamsters had unrestricted access to food and water,
and were allowed acclimatization to the experimental conditions for seven days prior to SARS-CoV-2 infection. According to stipu-
lations of the animal use permit, high caloric feed (oilseed) was offered to all animals once the first animal in a group had presented
with a body weight loss of > 10% at day two post infection. Cage temperatures and relative humidities were recorded daily and
ranged from 22 to 24C and 45 to 60%, respectively. The defined humane endpoints included > 15% weight loss for > 48 h or >
20% weight loss.




Hamsters of each species were randomly distributed into two groups: SARS-CoV-2-infected (Roborovski dwarf hamsters: n =
10, Campbell’s dwarf hamsters: n = 12 and Djungarian hamsters: n = 12; 1x105 plaque forming units (pfu) in a volume of 30 ml)
and mock-infected (n = 12 per species; 30 ml of cell culture supernatant from uninfected Vero E6 cells). The infection was per-
formed as previously described (Osterrieder et al., 2020). In extension of our initial trial, we infected three of the previously
mock-infected Roborovski dwarf hamsters one week later with 5x103 pfu (in 20 mL volume) to test for dose-dependent out-
comes of the infection. Body weights of all hamsters and body temperatures of at least 3 hamsters per group were recorded
daily and clinical signs of all animals were monitored twice daily throughout the experiment. On days 2, 3, 5 and 14 post infec-
tion, three hamsters were euthanized either randomly assigned or because they had reached defined humane endpoints by the
respective day post infection. Euthanasia was applied by exsanguination under general anesthesia as described (Nakamura
et al., 2017). Whole-blood, tracheal swabs, lungs (left and right), kidneys and parts of the jejunum were collected for virus titra-
tions, RT-qPCR and/or histopathological examinations. All organs were preserved in 4% formalin for subsequent in-depth his-
topathological investigations.
Histopathology and in situ-hybridization
For histopathology and localization of viral RNA by in situ-hybridization (ISH), the left lung lobe was carefully removed and immersion
fixed in buffered 4% formalin, pH 7.0, for 48 h. Lungs were embedded in paraffin and cut at 2 mm thickness. Sections were stained
with hematoxylin and eosin (HE) and periodic acid-Schiff (PAS) reaction followed by blinded microscopic evaluation by board certi-
fied veterinary pathologists (K.D., A.D.G.) (Gruber et al., 2020). For ISH, the ViewRNA ISH Tissue Assay Kit (Invitrogen by Thermo
Fisher Scientific, Darmstadt, Germany) was used following the manufacturer’s instructions with minor adjustments. Probe for the
detection of the N gene RNA of SARS-CoV-2 (NCBI database NC_045512.2, nucleotides 28,274 to 29,533, assay ID: VPNKRHM)
was employed. Lung sections of 2 mm thickness mounted on adhesive glass slides were dewaxed in xylol and dehydrated in graded
ethanols. Tissues were incubated at 95C for 10 min and subsequently protease digested for 20 min. Sections were fixed with 4%
paraformaldehyde dissolved in phosphate buffered saline (PBS) and hybridized with the probes. Amplifier and label probe hybridiza-
tions were performed according to the manufacturer’s instructions using fast red as chromogen. Sections were counterstained with
hematoxylin for 45 s, washed in tap water for 5 min, and mounted with Roti-Mount Fluor-Care DAPI (4, 6-diaminidino-2-phenylin-
dole; Carl Roth). An irrelevant probe for the detection of streptococcal pneumolysin was used as a control for sequence-specific
binding. HE and PAS-stained and ISH slides were analyzed and photographed using an Olympus BX41 microscope with a DP80 Mi-
croscope Digital Camera and the cellSens Imaging Software, Version 1.18 (Olympus Corporation, M€unster, Germany). For overviews
with lower magnification, slides were automatically digitized using the Aperio CS2 slide scanner (Leica Biosystems Imaging Inc.,
Vista, CA, USA) and image files were generated using the Image Scope Software (Leica Biosystems Imaging Inc.). The same exper-
imental procedures were used to evaluate brain tissues.Cell Reports 33, 108488, December 8, 2020 e2
Report
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To assess virus titers from 50 mg lung tissue, tissue homogenates were prepared using a bead mill (Analytic Jena) and 10-fold serial
dilutions were prepared in MEM-10% FBS, which were then added to Vero E6 cells in 12-well-plates Likewise, titrations were per-
formed on 10-fold serial dilutions of whole blood samples. The dilutions were removed after 2 h and cells were overlaid with 1.25%
carboxy-methylcellulose (viscosity 400 cP, Sigma) in MEM-10% FBS. Three days later, cells were formalin-fixed, stained with crystal
violet, and plaques were counted. RNA was extracted from 25mg lung homogenates, 25 mg jejunal and kidney tissue samples, 25 ml
blood and tracheal swabs using the innuPREP Virus RNA kit (Analytic Jena). Viral RNA copies were quantified in 10% of the obtained
eluate volume with a one-step RT-qPCR reaction using a standard curve and the NEB Luna Universal Probe One-Step RT-qPCR kit
(New England Biolabs) and previously published TaqMan primers and probe (SARS-CoV-2 E_Sarbeco; Table S3) (Corman et al.,
2020) on a StepOnePlus RealTime PCR System (Thermo Fisher Scientific).
ACE-2 PCR and sequencing
The complete coding sequence (CDS) of ACE-2 ofP. campbelliwas determined previously (GQ262790). The complete protein coding
sequence of ACE-2 of P. roborovskii was determined from its mRNA sequence. Total RNA was isolated from the lungs of 2 different
Roborovski dwarf hamsters. Harvested lung tissue samples were submersed in RNAlater solution (Thermo Fisher Scientific) to sta-
bilize and protect cellular RNA. The tissues were homogenized and total RNAwas isolated with InviTrap Spin Cell RNAMini kit (Invitec
Molecular). RNA (500 ng) was converted to complementary DNA (cDNA) by using the Moloney murine leukemia virus reverse tran-
scriptase (Promega) and random hexamer primers. Next, cDNA was amplified as three overlapping fragments spanning the entire
protein coding region of ACE-2 using ACE-2-specific primers and the high-fidelity DNA polymerase Phusion (Thermo Fisher Scien-
tific). The primers were designed to bind regions that are conserved across four species of the family Cricetidae (Cricetulus griseus,
Mesocricetus auratus, Peromyscus maniculatus bairdii and Phodopus campbelli) with known complete cDNA (Table S3). PCR prod-
ucts were purified and sequenced by Sanger sequencing. The complete CDS of ACE-2 of P. sungorus was predicted from the
genomic sequence of P. sungorus (GenBank GCA_001707965.1) based on sequence similarity. The sequence of ACE-2 is highly
conserved across mammalian species (Zhai et al., 2020). The ACE-2 gene of Cricetulus griseus,Mesocricetus auratus, Peromyscus
maniculatus bairdii and Phodopus campbelli contains 18 exons. To identify the CDS of ACE-2 of P. sungorus, the ACE-2 exon se-
quences of P. campbelli and the ACE-2 exon sequences of P. roborovskii that were identified in this study, were aligned individually
against the available genomic reads of P. sungorus using the BLAST program and the complete CDS was derived from the obtained
alignments. The complete predicted ACE-2 CDS of P. roborovskii and P. sungoruswere submitted to GenBank (Accession numbers
pending). Complete alignments of ACE-2 protein sequences are supplied as supplementary information (Figure S2).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using Graph-Pad Prism (GraphPad Software Inc., San Diego, CA, USA). Statistical details of all
analyzed experiments can be found in the respective figure legends. Data were considered significant if p % 0.05.e3 Cell Reports 33, 108488, December 8, 2020
